Biomea Fusion : Presentation for Conference Call to Discuss

COVALENT-111: Phase II


First Data Readout of Initial Healthy Volunteer and Type 2 Diabetes Mellitus Cohorts


March 28, 2023


... | March 28, 2023

Related Keywords

Juan Frias , Steve Morris , Thomas Butler , Rohit Kulkarni , Exchange Commission , Professor Of Medicine Harvard Medical School , Joslin Diabetes Center , Biomea Fusion Inc , While The Company , Board Co , Principal Investigator Of Velocity Clinical Research , Beta Cell Health , Data Readout , Initial Healthy Volunteer , Biomea Fusion , Operating Officer , Principal Investigator , Velocity Clinical Research , Scientific Advisory Board Member , Harvard Medical School , Faculty Member , Advisory Board Member , Medical Officer , Executive Officer , Beta Cell , Beta Cell Loss , Diabetes Therapies , Beta Cell Mass , Glucose Tolerance , Impaired Glucose Tolerance , Insulin Resistance , Beta Cell Workload , Beta Cell Failure , Nc Stock Exchange , News , Information , Press Release , Hase , First , Data , Readout , F , Nitial , Healthy , Volunteer , End , Type , , Diabetes , Mellitus , Arch Bmea Us09077a1060 ,